Come hear representatives from the National Cancer Institute (NCI), National Institute of Neurological Disorders and Stroke (NINDS), National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID) provide an overview of how a wide range of stakeholders can work with NIH, as well as the value-add it brings to advancing cutting-edge research to the patient and marketplace with drugs, med-tech (including wearables), diagnostics, digital health and combination products.